|
Thursday, 17 September 2009 |
|
GSK Refuses to Say What UK Pays for H1N1 Vaccine
'GlaxoSmithKline again refused to disclose yesterday how much the UK Government is paying for as many as 132 million doses of the H1N1 swine flu vaccine it has ordered from the group.
Europe's biggest drugs company, which along with rival Baxter will supply the Government with the vaccine, said at the time of its second-quarter results in July that it was charging developed countries €7 a dose for the treatment. The British Government is getting a discount, but neither the company, nor the Department of Health is prepared to say how much GSK is earning from Britain.'
Read more...
|
